Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial

BMC Psychiatry
Jocelyn Fotso SohSoham Rej

Abstract

Lithium is the gold-standard treatment for bipolar disorder, is highly effective in treating major depressive disorder, and has anti-suicidal properties. However, clinicians are increasingly avoiding lithium largely due to fears of renal toxicity. Nephrogenic Diabetes Insipidus (NDI) occurs in 15-20% of lithium users and predicts a 2-3 times increased risk of chronic kidney disease (CKD). We recently found that use of statins is associated with lower NDI risk in a cross-sectional study. In this current paper, we describe the methodology of a randomized controlled trial (RCT) to treat lithium-induced NDI using atorvastatin. We will conduct a 12-week, double-blind placebo-controlled RCT of atorvastatin for lithium-induced NDI at McGill University, Montreal, Canada. We will recruit 60 current lithium users, aged 18-85, who have indicators of NDI, which we defined as urine osmolality (UOsm) < 600 mOsm/kg after 10-h fluid restriction. We will randomize patients to atorvastatin (20 mg/day) or placebo for 12 weeks. We will examine whether this improves measures of NDI: UOsm and aquaporin (AQP2) excretion at 12-week follow-up, adjusted for baseline. Not applicable. The aim of this clinical trial is to provide preliminary data about the...Continue Reading

Associated Clinical Trials

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Nov 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·R C YoungD A Meyer
Nov 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R BotonD C Batlle
Feb 14, 1985·The New England Journal of Medicine·D C BatlleM Grupp
Dec 15, 1994·Statistics in Medicine·M A Birkett, S J Day
Nov 14, 1997·Biological Psychiatry·E G AltmanJ M Davis
Jun 17, 2003·PharmacoEconomics·Leah KleinmanDennis Revicki
Apr 17, 2004·Journal of the American Geriatrics Society·David N JuurlinkDonald A Redelmeier
Jan 12, 2008·International Journal of Geriatric Psychiatry·Els J M van MelickToine C G Egberts
Jul 4, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Jennifer J BedfordRobert J Walker
Oct 4, 2008·Psychiatric Services : a Journal of the American Psychiatric Association·Ross BaldessariniLeslie Leahy
Apr 23, 2009·Nature Reviews. Nephrology·Jean-Pierre Grünfeld, Bernard C Rossier
Feb 24, 2011·Nephrology·Giovanni F M StrippoliPaul Mitchell
Apr 3, 2012·Journal of Geriatric Psychiatry and Neurology·Soham RejKenneth Shulman
May 23, 2013·European Journal of Clinical Nutrition·E PerrierA Klein
Jul 12, 2013·JAMA : the Journal of the American Medical Association·Christopher J L MurrayUNKNOWN U.S. Burden of Disease Collaborators
Oct 8, 2013·Mayo Clinic Proceedings·Kristopher J SwigerSeth S Martin
Jan 8, 2014·Postgraduate Medicine·Prakash C Deedwania
Feb 26, 2014·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Soham RejAndrea Gruneir
Mar 15, 2014·ACS Chemical Neuroscience·Janusz K Rybakowski
Jul 10, 2014·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Soham RejKarl Looper
Jul 30, 2014·Bipolar Disorders·James Conor KinahanBrendan D Kelly
Sep 13, 2014·The American Journal of Cardiology·Steven M LillyIshak A Mansi
Jan 24, 2015·The British Journal of Psychiatry : the Journal of Mental Science·Tobias GerhardMark Olfson
Jul 6, 2015·Journal of Affective Disorders·Rif S El-MallakhS Nassir Ghaemi
Feb 5, 2016·Lancet·Brian ShineJohn Geddes
Oct 26, 2016·BMJ : British Medical Journal·Sandra M EldridgeUNKNOWN PAFS consensus group

❮ Previous
Next ❯

Citations

Sep 15, 2020·American Journal of Physiology. Renal Physiology·Line Aas MortensenGitte Rye Hinrichs

❮ Previous
Next ❯

Software Mentioned

Redcap

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Related Papers

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
Soham RejKarl Looper
The American Journal of Psychiatry
T R Kosten, J N Forrest
The American Journal of Psychiatry
T R Price, P J Beisswenger
© 2022 Meta ULC. All rights reserved